BioWorld

Feb. 23, 2009

View Archived Issues

Stock Winners and Losers For The Week

The Sky Hasn't Fallen, But It May Not Be as Blue

Oh, to be a fly on the wall in a room full of bankers and investors! Read More

Biotechnology Company Deals With Other Biotechnology Companies: Dec. 19, 2008 - Feb. 18, 2009

Biotechnology Company Deals With Miscellaneous Companies: Dec. 19, 2008 - Feb. 18, 2009

Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Dec. 19, 2008 - Feb. 18, 2009

Biotech-Biotech Collaborations: Modified Agreements: Dec. 19, 2008 - Feb. 18, 2009

Debt Woes Loom Large For Struggling Drugmakers

Recent headlines show the bad news has been mounting for months as biotech firms, struggling to raise cash, announced layoffs, corporate restructurings and bankruptcy filings. Read More

Money Raised Year to Date

BioWorld Stock Report For Public Biotechnology Companies

Today's news in brief

BioWorld

BioWorld briefs for Dec. 15, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 12, 2025.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.

CT scan of brain showing subdural hematoma

FDA greenlights Medtronic Onyx subdural hematoma treatment

BioWorld MedTech

Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...